Literature DB >> 11474440

Prognostic factors in arthrocentesis of the temporomandibular joint: evaluation of 100 patients with internal derangement.

M Nishimura1, N Segami, K Kaneyama, T Suzuki.   

Abstract

PURPOSE: The goal of this study was to analyze the prognostic factors for successful arthrocentesis for internal derangement (ID) of the temporomandibular joint (TMJ). PATIENTS AND METHODS: Arthrocentesis was carried out as the initial treatment in 103 TMJs of 100 patients with ID. The effectiveness of the treatment was evaluated in terms of the postoperative range of maximal mouth opening (MMO) and the degree of preoperative pain on a visual analog scale (VAS). Prognostic factors analyzed were age, sex, duration of painful locking, preoperative and postoperative range of MMO, preoperative degree of pain, preoperative clicking on opening mouth before becoming locked, and magnetic resonance imaging (MRI) findings. These factors were statistically analyzed.
RESULTS: Seventy-three cases (71%) satisfied the criteria for success. One week after the procedure, the mean range of MMO in the successful cases (43.8 +/- 5.5 mm) was significantly greater than that in unsuccessful cases (36.9 +/- 6.6 mm) (P <.05). The mean preoperative degree of pain on a VAS in successful cases (4.7 +/- 2.9) was significantly smaller than that in unsuccessful cases (6.2 +/- 2.1) (P <.05). The preoperative incidence of morphologic changes in the mandibular condyle seen on MRI of successful cases was significantly less than that in unsuccessful cases (P <.05).
CONCLUSION: Severe preoperative pain, relapse in the amount of mouth opening within 1 week after arthrocentesis, and preoperative bony changes in the condyle may be predictors of the effectiveness of arthrocentesis for ID of the TMJ. Copyright 2001 American Association of Oral and Maxillofacial Surgeons

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474440     DOI: 10.1053/joms.2001.25019

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  8 in total

1.  Sodium hyaluronate: an effective adjunct in temporomandibular joint arthrocentesis.

Authors:  Poornima Patel; Faisal Idrees; Vilas Newaskar; Deepak Agrawal
Journal:  Oral Maxillofac Surg       Date:  2016-10-06

Review 2.  Temporomandibular joint arthrocentesis. Review of the literature.

Authors:  Florencio Monje-Gil; Dorrit Nitzan; Raul González-Garcia
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-07-01

3.  Relationship between the Effectiveness of Arthrocentesis under Sufficient Pressure and Conditions of the Temporomandibular Joint.

Authors:  Shinya Yura; Kazuhiro Ooi; Yuri Izumiyama
Journal:  ISRN Dent       Date:  2011-05-31

4.  Clinical factors affecting the outcome of arthocentesis.

Authors:  Syed Wakeel Andrabi; Altaf H Malik; Ajaz A Shah
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-02-26

5.  Classification of temporomandibular joint internal derangement based on magnetic resonance imaging and clinical findings of 435 patients contributing to a nonsurgical treatment protocol.

Authors:  Ayman F Hegab; Hossam IAbd Al Hameed; Khaled Said Karam
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

6.  Evaluation of Patient Comfort and Impact of Different Anesthesia Techniques on the Temporomandibular Joint Arthrocentesis Applications by Comparing Gow-Gates Mandibular Block Anesthesia with Auriculotemporal Nerve Block.

Authors:  Onur Atalı; Elif Özçelik; Onur Gönül; Hasan Garip
Journal:  Pain Res Manag       Date:  2022-08-31       Impact factor: 2.667

7.  Influencing factor on the prognosis of arthrocentesis.

Authors:  Yoon Ho Kim; Tae Min Jeong; Kang Mi Pang; Seung Il Song
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-08-26

8.  Healthcare utilisation and costs for temporomandibular disorders: a descriptive, cross-sectional study.

Authors:  Hyejin Seo; Boyoung Jung; Jiyoon Yeo; Koh-Woon Kim; Jae-Heung Cho; Yoon Jae Lee; In-Hyuk Ha
Journal:  BMJ Open       Date:  2020-10-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.